VAM
IMA

Vazirani Asset Management’s ImageneBio Inc IMA Stock Holding History

Vazirani Asset Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,083
Closed -$41K – 20
2024
Q4 		$41K Sell
2,083
-7,556
-78% -$153K 0.13% 19
2024
Q3 		$200K Buy
+9,639
New +$195K 0.36% 21

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vazirani Asset Management's IMA Position: Q1 2025 in Review

Vazirani Asset Management sold out of ImageneBio Inc (IMA) in Q1 2025, closing a stake of 2,083 shares — an estimated $41K sold.

Vazirani Asset Management first reported a position in IMA in Q3 2024 and held it in 2 quarters. The position peaked at $200K in Q3 2024. 45 funds tracked by Wall St. Rank hold IMA as of Q1 2025.

  • Vazirani Asset Management reported no remaining ImageneBio Inc position as of Q1 2025 after selling out during the quarter.
  • Vazirani Asset Management sold 2,083 ImageneBio Inc shares in Q1 2025, an estimated $41K.
  • Vazirani Asset Management first reported a position in ImageneBio Inc in Q3 2024 and held it in 2 quarters.
  • Vazirani Asset Management's ImageneBio Inc position peaked at $200K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2025.

Based on Vazirani Asset Management's 13F filing for Q1 2025, filed 15 May 2025.